脊髓Neuroplastin 65通过GABAA受体α2亚基调控参与神经病理性疼痛
该研究在雄性Sprague-Dawley大鼠慢性压迫性损伤(CCI)模型中观察到脊髓NP65蛋白和mRNA表达显著降低(P < .05;ANOVA)。鞘内注射过表达NP65的腺相关病毒(AAV)可显著缓解CCI大鼠疼痛行为并上调GABAAR-α2水平。体外实验表明NP65通过钙调神经磷酸酶-NFATc4(CaN-NFATc4)信号通路调控GABAAR-α2表达。
要点
- CCI大鼠脊髓NP65蛋白和mRNA表达显著降低(P < .05;ANOVA)。
- 鞘内过表达NP65可缓解CCI大鼠疼痛行为并上调GABAAR-α2。
- NP65通过CaN-NFATc4信号通路调控GABAAR-α2水平。
核心结论
- NP65通过CaN-NFATc4信号通路调控GABAAR-α2水平,可能是神经病理性疼痛的潜在机制。
研究设计与样本
- 雄性Sprague-Dawley大鼠建立慢性压迫性损伤(CCI)疼痛模型,验证脊髓NP65表达变化。
- CCI大鼠鞘内注射过表达NP65的腺相关病毒(AAV),观察疼痛行为与GABAAR-α2蛋白表达。
- 体外Neuroblastoma 2a细胞通过质粒或小干扰RNA调控NP65表达,评估CaN-NFATc4通路对GABAAR-α2的影响。
主要发现
- CCI组NP65蛋白和mRNA表达水平显著降低(P < .05;ANOVA)。
- 鞘内注射过表达NP65的AAV后,CCI大鼠疼痛行为显著缓解,GABAAR-α2水平上调。
- 体外实验证实调控NP65表达可改变GABAAR-α2、CaN及磷酸化NFATc4的表达。
- 应用特异性CaN抑制剂环孢素A(CsA)后,NP65表达变化不再引起GABAAR-α2、CaN或磷酸化NFATc4蛋白的后续变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neuropathic pain (NP) is a highly challenging condition with complex pathological mechanisms, and the spinal gamma aminobutyric acid A receptor receptor plays a crucial role in its progression. Recent studies have revealed a potential interaction between neuroplastin 65 (NP65) and gamma aminobutyric acid A receptor α2 subunit (GABAAR-α2) on the cell surface. We hypothesize that NP65 is involved in the pathogenesis of NP by regulating the level of GABAAR-α2. METHODS: A chronic constrictive injury (CCI) pain model was established in male Sprague-Dawley rats to verify the change in spinal NP65 expression. Alterations in pain behavior and GABAAR-α2 protein expression were observed after intrathecal injection of NP65 overexpressing adeno-associated virus (AAV) in CCI rats. In vitro investigations on Neuroblastoma 2a cells, the effect of NP65 on GABAAR-α2 expression via the calcineurin-nuclear factor of activated T-cell 4 (CaN-NFATc4) signaling pathway was evaluated by manipulating NP65 expression. RESULTS: The expression level of NP65 protein and mRNA in the CCI group were significantly decreased ( P < .05; analysis of variance [ANOVA]). After intrathecal injection of NP65, overexpression of AAV and pain behavior in CCI rats were significantly alleviated, and levels of GABAAR-α2 were upregulated. In vitro experiments verified alterations in the expression of GABAAR-α2, CaN, and phosphorylated NFATc4 on the application of NP65 with plasmid or small interfering RNA, respectively. After the application of the specific CaN inhibitor cyclosporine A (CsA), the changes in NP65 expression did not produce subsequent alterations in the expression of GABAAR-α2, CaN, or phosphorylated NFATc4 proteins. CONCLUSIONS: NP65 modulates the level of GABAAR-α2 through the CaN-NFATc4 signaling pathway, which may serve as the underlying mechanism of NP.
引用
- Xu L, Wang Y, Jiao Y, et al. Involvement of Spinal Neuroplastin 65 in Neuropathic Pain by GABAA Receptor α2 Subunit Regulation. Anesth Analg. 2024. PMID: 38507554. doi:10.1213/ANE.0000000000006964
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。